液态酶法测定糖化白蛋白在2型糖尿病合并低血清白蛋白患者中的临床价值
[Abstract]:Objective: Diabetes mellitus (DM) is a chronic systemic metabolic disease whose incidence increases year by year. At present, the most commonly used glucose monitoring methods are time-point blood glucose and glycosylated hemoglobin (Hb). Although these two tests can meet the needs of diagnosis and blood glucose monitoring in most diabetics, it is not possible to accurately reflect patient's blood glucose changes in many cases, such as explosive type 1 diabetes and iron deficiency anemia[1]. Glycated albumin (GA) is an important indicator of diabetic blood sugar level, which is more sensitive to blood sugar change than glycosylated hemoglobin, and can reflect the blood glucose control level of nearly 2 to 3 weeks. In this study, GA was determined by liquid enzyme method, and its correlation with fasting plasma glucose (FPG) and Hb concentration was studied and its clinical value in patients with type 2 diabetes mellitus complicated with low serum albumin was discussed. Methods: 164 patients with type 2 diabetes hospitalized in our hospital from July 2013 to May 2014 were included in this study, including 89 males and 75 females with an average age (52. 66, 9. 51). 132 patients with type 2 diabetes mellitus and 32 patients with type 2 diabetes mellitus complicated with serum albumin (38g/ L). All patients met the 1999 WHO criteria for diagnosis and classification of diabetes mellitus, all of which have no genetic relationship with each other in the Hebei region. Patients enrolled exclude anemia, pregnancy, liver dysfunction (ALT or AST exceeding the upper limit of the reference range), nephrotic syndrome, thyroid disease, acute complications of diabetes, and patients undergoing treatment with corticosteroids. During the same period, 145 patients were enrolled in this study, including 80 males and 65 females, with an average age (52. 51, 8. 24), all of which belong to the northern region of the Hebei region, unrelated to each other, with the exception of diabetes mellitus, hypertension, and renal disease. All incoming sex, age, height, body weight were recorded and the Body mass index (BMI) was calculated. All subjects signed informed consent to comply with the medical ethics requirements. All patients with type 2 diabetes were divided into diabetes group (DM group, n = 164) and normal control group (NC group, n = 145). Serum albumin (ALB38g/ L) was divided into two groups: (1) low serum albumin group (LA group, n = 32), among them 18 males and 14 females, mean age (52. 56, 9. 63); (2) Normal serum albumin (NA group, n = 277), among which 151 males and 126 females were females. Mean age (52. 59/ 8. 86). The levels of GA, FPG, Hb concentration and serum albumin (Albumin) in each group were measured, and the correlation between GA and various indexes was studied. Statistical analysis: Statistical analysis of the results was carried out by SPSS 10.0 statistical software. All the measured data were represented by mean square deviation (x/ s), and the positive state and homogeneity were tested. The paired t test was used for the difference in the group, and the difference between the groups was tested with two independent samples. Linear correlation and regression analysis and covariance analysis were used to analyze the correlation between GA and Hb, and the difference between FPG and Hb was statistically significant. Results: (1) There was no statistical difference between group 1 DM and NC group (P <0.05). Compared with NC group, the BMI of DM group increased significantly (P0.05). The levels of FPG and Hb were significantly higher in DM group (P <0.01); (3) In DM group, GA, FPG and Hb were significantly lower in DM group than before treatment (P <0.01); (4) in NC group, GA and FPG (r = 0.159, P0.05), Hb (r = 0.870). In DM group, GA was positively correlated with FPG (r = 0.494, P0.01), Hb (r = 0.9918, P0.01). After 2 weeks of treatment, GA was positively correlated with FPG (r = 0.387, P0.01), Hb (r = 0.789,P0.01). (5) The regression analysis equation of GA before and after treatment of patients with DM group was Y = 0.945X-7.58, and the regression analysis equation of Hb concentration before and after treatment was Y = 0.9X-1.77. The change value of FPG before and after treatment (FPG = before treatment, FPG before treatment) and the regression analysis equation of FPG before treatment were Y = 0.95X-5.77, and the slope of the visible GA was smaller than FPG (0.04572.0. 91). The indexes between group 2 LA and NA group: (1) LA group compared with NA group, sex R%, age, height, body weight, There was no statistical difference in BMI (P0.05), and the two groups were comparable; (2) Compared with NA group, the levels of GA, FPG and Hb of LA group were significantly higher, the difference was significant (P0.05), the difference was significantly lower (P <0.01), and (3) in NA group, GA and FPG (r = 0.809, P0.01). In group LA, GA and FPG (r = 0.722, P0.01), Hb (r = 0.9938, P0.01) were positively correlated; (5) The regression analysis equation of GA and Hb in NA group was Y = 2.93X-0.16.The regression analysis equation of GA and Hb in group LA was Y = 2.64X + 2.18, and was detected by interaction effect. There was no statistical difference between the two slopes (F = 3. 209, P0.05), and covariance analysis could be carried out; (6) The effect of Hb concentration in LA group and NA group on GA was analyzed by covariance analysis method. Results The results of covariate Hb relaxation were (F = 3452. 150, P 0.01), suggesting that Hb concentration had a significant effect on GA level. The results were (F = 0. 241, P0.05), suggesting that there was no significant effect on GA level. Conclusion: 1 The liquid enzymatic method has a good correlation with FPG and Hb, which can reflect the blood glucose level of the subjects, and can be used as the blood sugar monitoring index of type 2 diabetes patients. The liquid enzymatic method can reflect the control of blood glucose in short term (2-3 weeks). Its sensitivity to blood sugar change is better than Hb, stability is better than that of time point blood sugar. 3 liquid enzyme method to determine GA, not affected by serum albumin level, can accurately reflect the subject's short-term blood sugar change.
【学位授予单位】:河北医科大学
【学位级别】:硕士
【学位授予年份】:2015
【分类号】:R587.1
【参考文献】
相关期刊论文 前10条
1 Teresa Ruiz Gracia;Nuria García de la Torre Lobo;Alejandra Durán Rodríguez Hervada;Alfonso L Calle Pascual;;WJD 5~(th) Anniversary Special Issues(2): Type 2 diabetes Structured SMBG in early management of T2DM: Contributions from the St Carlos study[J];World Journal of Diabetes;2014年04期
2 戴静怡;李青;汪年松;盛晓华;程东生;简桂花;许涛;崔勇平;俞岗;薛勤;王筱霞;高许萍;;糖化白蛋白在CKD3~5期非透析和血液透析合并糖尿病患者中的血糖评估价值[J];中国中西医结合肾病杂志;2013年11期
3 吕冰;王立;;2型糖尿病患者平均血糖值与糖化白蛋白相关性研究[J];疑难病杂志;2013年02期
4 黄田海;毛雁飞;马兰花;谭琳琳;;糖化清蛋白检测临床意义研究进展[J];国际检验医学杂志;2012年18期
5 张晋;;2型糖尿病患者血清糖化白蛋白水平与糖尿病肾病的相关性分析[J];重庆医科大学学报;2010年01期
6 晋溶辰;黄金;杨玲凤;;糖尿病患者生活质量的研究现状[J];医学综述;2010年02期
7 李青;吴松华;屠印芳;唐峻岭;潘洁敏;李鸣;周健;贾伟平;项坤三;;评价糖尿病患者住院期间降糖疗效的有效指标——糖化血清白蛋白[J];上海医学;2009年12期
8 丁风华;陆林;蒲里津;张建盛;张瑞岩;胡健;张奇;杨震坤;陈秋静;沈卫峰;;糖化白蛋白与糖尿病并发冠心病的关系[J];中国动脉硬化杂志;2008年02期
9 李淑彦;吴松华;李青;;糖化血清白蛋白与血糖、糖化血红蛋白相关性研究[J];临床荟萃;2007年22期
10 李青;吴松华;潘洁敏;唐峻岭;张扬;陆惠娟;包玉倩;贾伟平;项坤三;;住院糖尿病患者的糖化血清白蛋白水平及其影响因素[J];中华医学杂志;2007年42期
,本文编号:2258484
本文链接:https://www.wllwen.com/yixuelunwen/nfm/2258484.html